← Leaderboards
Caroline Breese Hall
University Of Rochester
$4,856,013
Attributed
$4,856,013
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $634.5K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$4,856,013 · 7
By mechanism
R01$4,711,811 · 2
M01$144,202 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Margot Mayer-Proschel$10,434,835
- Gretchen Lano Birbeck$12,919,100
- Jean M Bidlack$6,851,551
- Ronnie Guillet$2,498,178
- David Mock$360,894
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Herpesvirus 6Human SubjectCommunicable Disease TransmissionEpidemiologyHerpesviridae DiseaseCongenital InfectionVirus Infection MechanismDevelopmental NeurobiologyVirus LoadPolymerase Chain ReactionInfant Human (0-1 Year)Longitudinal Human StudyTissue /Cell CultureBehavioral /Social Science Research TagHumoral ImmunitySalivaInformation SystemsEnzyme Linked Immunosorbent AssayPediatricsCommunity Health ServicesHuman DataCytokineBlood Chemistry
Grant awards (17)
Congenital HHV6 Infection: Characteristics and Outcome$584,464
R01 · FY2007 · HD · contact PI
Congenital HHV6 Infection: Characteristics and Outcome$608,346
R01 · FY2006 · HD · contact PI
Congenital HHV6 Infection: Characteristics and Outcome$625,243
R01 · FY2005 · HD
HHV6 INFECTION: CHARACTERISTICS AND OUTCOME$9,275
M01 · FY2005 · RR
Congenital HHV6 Infection: Characteristics and Outcome$627,723
R01 · FY2004 · HD
Primary HHV-6 Infection: Clinical and Viral Characteristics$32,744
M01 · FY2004 · RR
HHV6 Infection: Characteristics and Outcome$13,762
M01 · FY2004 · RR
Congenital HHV6 Infection: Characteristics and Outcome$642,286
R01 · FY2003 · HD
PRIMARY HHV-6 INFECTION--CLINICAL &VIRAL CHARACTERISTICS$0
M01 · FY2002 · RR
COMMUNITY SURVEILLANCE OF INFECTIOUS DISEASE IN MONROE COUNTY$0
M01 · FY2002 · RR
PRIMARY HHV6 INFECTION--CLINICAL &VIRAL CHARACTERISTICS$822,451
R01 · FY2001 · AI
PHASE II STUDY OF MEDI-493 FOR PROPHYLAXIS OF SEVERE RSV DISEASE$19,613
M01 · FY2001 · RR
PRIMARY HHV-6 INFECTION--CLINICAL &VIRAL CHARACTERISTICS$19,613
M01 · FY2001 · RR
COMMUNITY SURVEILLANCE OF INFECTIOUS DISEASE IN MONROE COUNTY$19,613
M01 · FY2001 · RR
PRIMARY HHV6 INFECTION--CLINICAL &VIRAL CHARACTERISTICS$801,298
R01 · FY2000 · AI
PRIMARY HHV-6 INFECTION--CLINICAL &VIRAL CHARACTERISTICS$14,791
M01 · FY2000 · RR
COMMUNITY SURVEILLANCE OF INFECTIOUS DISEASE IN MONROE COUNTY$14,791
M01 · FY2000 · RR